Design, simulate, refine: simulation-guided clinical trials for accelerated drug development.

Simulation-guided clinical trial design enhances decision-making and accelerates drug development by optimizing complex adaptive strategies.

• Why it matters: Innovative trial approaches improve discovery but add complexity, making it challenging to ensure reliability, safety, and efficiency in drug development processes.
• What they did: The authors used simulation studies to evaluate trial operating characteristics, including error control, power, and adaptive decision probabilities, supporting design refinement and communication.
• The result: This approach enables more rigorous, transparent, and practical trial designs, ultimately facilitating the delivery of safe, effective therapies to patients more efficiently.